Reisa Sperling MD

Dr. Reisa Sperling is a neurologist focused on the detection and treatment of Alzheimer’s disease, even before clinical symptoms are evident. She is the co-Principal Investigator, with Dr. Keith Johnson, of the Harvard Aging Brain Study in Boston. Her research uses neuroimaging and cognitive tests to understand the aging brain and the earliest changes associated with Alzheimer’s disease. Dr. Sperling is a Professor in Neurology at Harvard Medical School, Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital, and Director of Neuroimaging for the Massachusetts ADRC at Massachusetts General Hospital. Dr. Sperling led the NIA-Alzheimer’s Association workgroup to develop guidelines for “Preclinical Alzheimer’s disease,” and currently serves on the Advisory Council of the National Institute on Aging. Dr. Sperling is also the Project Leader for the Anti-Amyloid Treatment in Asymptomatic AD (A4) study - a landmark secondary prevention trial in over 1000 clinically normal older individuals with PET amyloid imaging evidence of early Alzheimer’s disease pathology. Dr. Sperling is a 2015 awardee of the American Academy of Neurology Potamkin Prize, and was named one of the 2017 Most Disruptive Women to Watch in Healthcare.

Keith Johnson MD

Dr. Johnson is a Professor of Radiology and Neurology at the Harvard Medical School. He is also an Associate Radiologist and the Director of Molecular Neuroimaging in the Division of Nuclear Medicine and Molecular Imaging at the Massachusetts General Hospital (MGH). He also serves as an associate physician and staff neurologist in the Memory Disorders Unit at the Brigham and Women's Hospital as well as a Clinical Associate in Neurology at the MGH. He is co-director of the Neuroimaging Program of the Massachusetts Alzheimer's Disease Research Center and its Dominantly Inherited Alzheimer Network (DIAN) research initiatives. He oversees the Clinical Brain Positron Emission Tomography (PET) Service at the MGH and also practices as a neurologist that specializes in neurodegenerative disorders. Dr. Johnson also maintains an Internet teaching atlas of neuroimaging known as the Whole Brain Atlas. His major research interests include the early diagnosis and treatment monitoring of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies.

Randy Buckner PhD

Dorene Rentz PsyD

Dorene M. Rentz, PsyD, is a clinical neuropsychologist with dual appointments in the Departments of Neurology at Brigham and Women’s Hospital and Massachusetts General Hospital. She is an Associate Professor of Neurology at Harvard Medical School and serves as the Co-Director of the Center for Alzheimer Research and Treatment and the Director of Neuropsychology at the Massachusetts Alzheimer’s Disease Research Center. She is also the Clinical Core Leader of the Harvard Aging Brain Study and the Director of the Recruitment and Outreach Core. Her research focus has been on the early detection of preclinical Alzheimer’s disease, particularly in high functioning individuals. Her recent work involves exploring early cognitive changes using PET amyloid and tau imaging and sensitive memory techniques. She is leading the cognitive outcome assessment committee for the A4 secondary prevention trial in Preclinical Alzheimer’s disease and is a leader in developing optimal cognitive outcome measures for future Alzheimer Disease prevention studies. She helped develop the iPad cognitive battery in the A4 study and has explored the feasibility of doing iPad cognitive assessments in the clinic and home environments.

Trey Hedden PhD

Trey Hedden’s research group focuses on integrating multiple brain markers to help build a comprehensive picture of how aging and neurodegenerative disease affect the relation between brain function and cognition at an individual level. His published work has examined behavioral measures and neuroimaging measures of age-related decreases in memory and executive control processes. He has extensive experience in the design and use of task-based functional MRI to test how age-related changes impact memory and executive function, in using functional connectivity analyses of resting-state functional MRI data to characterize multiple brain networks, in estimating volume and cortical thickness of regions related to memory and executive function, and in the use of diffusion and T2-weighted imaging to detect white matter abnormalities. His current research integrates measures of functional MRI with PET markers of tau and amyloid accumulation, PET markers of dopamine dysfunction, PET markers of glucose metabolism, and MRI markers of white matter integrity to target potential preclinical Alzheimer’s related neuropathology in otherwise normal older individuals.

Dennis Selkoe MD

Bradley Hyman MD, PhD  

Deborah Blacker MD, PhD

Gad Marshall MD

Dr. Gad Marshall is board certified in Neurology. He is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. He has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and is currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 2, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living (ADL) and neuropsychiatric symptoms with PiB and FDG PET, structural and resting-state functional MRI, and CSF biomarkers across the early Alzheimer’s disease spectrum. Over the past several years, he developed and validated a new performance-based ADL test, the Harvard Automated Phone Task (APT), in which individuals navigate an interactive voice response system to refill a prescription (APT-Script), select a new primary care physician (APT-PCP), and make a bank account transfer and payment (APT-Bank). Building on this experience, he recently obtained philanthropic funding from two sources and started developing a smartphone app for the assessment of early ADL changes that consists of using a patient portal and calendar to perform various tasks on a smartphone.

Brad Dickerson MD

Jasmeer P. Chhatwal MD, PhD

Dr. Chhatwal is a research-oriented neurologist who is fascinated by the complex neurobiology that underlies human memory and the manner in which advanced age and neurodegenerative disease both diminish our capacity to form memories and recall information. He received his undergraduate degrees in biology and philosophy from Yale University, followed by Ph.D. (Neuroscience) and M.D. degrees from Emory University, and a Master's degree from Harvard Medical School. He moved to MGH and BWH in 2009 as a resident in Adult Neurology, and stayed on to do his fellowship in Memory Disorders at MGH. He is now an attending physician and scientist in the MGH Department of Neurology, and an instructor in neurology at Harvard Medical School. His current research uses multi-modal neuroimaging, pharmacology, and genetics to better understand what differentiates individuals aging normally from those early on the pathway to neurodegeneration and severe cognitive decline. He has a particular interest in genetic susceptibility to Alzheimer's disease, and serves as the MGH/BWH site leader for the Dominantly Inherited Alzheimer's Network (DIAN; headquartered at Washington University, Dr. Randall Bateman PI).

Nancy Donovan MD

Dr. Nancy Donovan’s research interests concern the natural history and pathophysiology of neuropsychiatric symptoms and social behavioral changes in Alzheimer’s disease (AD). She is most interested in identifying phenotypic behavioral changes in preclinical stage AD and understanding their relationship to AD biomarkers and clinical progression. As a Harvard Aging Brain Study (HABS) co-investigator since 2011, she has investigated the epidemiology and neuroimaging correlates of depression, anxiety, loneliness and social network measures in HABS and in other cohorts such as the Alzheimer’s Disease Neuroimaging Initiative, the Massachusetts Alzheimer’s Disease Research Center longitudinal cohort and the US Health and Retirement Study.

Scott McGinnis, MD

Jorge Sepulcre MD

Teresa Gomez-Isla MD, PhD

Aaron Schultz PhD

J. Alex Becker PhD

Rebecca E. Amariglio PhD

Rebecca E. Amariglio is an Assistant Professor in Neurology at Harvard Medical School and a clinical neuropsychologist with dual appointments at BWH and MGH.  Her research focuses on the early detection of Alzheimer’s disease, by developing and optimizing sensitive instruments that measure subtle cognitive and functional changes at the preclinical stage.  In particular, she is interested in whether subjective memory complaints can help predict risk of Alzheimer’s disease progression.  Previously, she has found that older individuals who report a greater number of cognitive complaints in their everyday functioning, are more likely to have increased amyloid burden and neurodegeneration, despite performing normally on cognitive measures in the clinic.  Dr. Amariglio is a core member of the Subjective Cognitive Decline-Iniative (SCD-I), an international working group of clinical researchers focused on developing consensus guidelines for Subjective Cognitive Decline, a transitional stage along the early Alzheimer’s disease trajectory prior to the onset of clinical impairment.

Yakeel Quiroz PhD

Dr. Quiroz is an Assistant Professor in the Departments of Psychiatry and Neurology at Massachusetts General Hospital/Harvard Medical School. She completed her PhD training in Clinical Psychology at Boston University and a postdoctoral fellowship in Neuropsychology at Mass General/Harvard Medical School. Currently, she is the Director of the Mass General Familial Dementia Neuroimaging Lab, and Co-Director of the Multicultural Neuropsychology Program (MUNDOS) at the Psychology Assessment Center. By applying her efforts to a large family that carries a genetic mutation that causes early-onset Alzheimer’s disease (AD), Dr. Quiroz’s research has focused on characterizing brain changes that may predispose individuals to develop memory loss or dementia later in life. Her work has already provided evidence of brain abnormalities in cognitively intact individuals at high risk for AD decades before their clinical onset. Her findings have helped the field to re-conceptualize Alzheimer's as a sequence of changes that begins decades before cognitive decline and which may be targeted by promising disease-slowing treatments. Dr. Quiroz also has strong clinical interests in the cognitive assessment of monolingual and bilingual Spanish-speaking patients. In her spare time she enjoys spending time with her family and friends, traveling to new places and listening to music.

Elizabeth Mormino PhD

Kate Papp PhD

Kathryn Papp, PhD is a clinical neuropsychologist with a primary interest in the early detection of Alzheimer’s disease (AD).  Her research focuses on the development of sensitive semantic and associative memory tests designed to identify individuals who may be at risk for AD progression. She is additionally interested in modifiable lifestyle factors which may mitigate cognitive decline in older adults.

Patrizia Vannini PhD

Patrizia Vannini’s current research project aims to investigate the neural underpinnings of memory self-awareness and the progressive dysfunction of these systems that underlies the loss of self-awareness with Alzheimer’s disease progression. Specifically, she uses a multimodal imaging approach, including the use of amyloid imaging (PiB-PET), structural MRI, and functional MRI during rest and task, to improve our understanding of the neural networks that support the ability to accurately assess one’s own memory performance and how early functional and pathological changes in these networks may portends decreased memory self-awareness and anosognosia.

Donald McLaren PhD

Willem Huijbers PhD 

Willem Huijbers’ research combines computational and neuroimaging methods to understand cognition and brain function across the lifespan. In his work, he specializes in statistical analysis of large amounts of magnetic resonance imaging (MRI) data. Within the Harvard Aging Brain Study, he has designed and conducted a series of experiments. Most of his work on Alzheimer’s disease evolves around the following question: When do increases in hippocampal activity delay or facilitate the development of cognitive impairment? Currently, he is affiliated with the Harvard Aging Brain study and developing a research group at Tilburg University in the Netherlands. Their work in Tilburg is focused on translation between MRI and PET data using deep convolutional networks. They hope to gain insight into the relation between different neuroimaging markers and develop tools to assist clinicians.

Rachel Buckley PhD

Rachel is a postdoctoral fellow in the Harvard Aging Brain study at Harvard Medical School/Massachusetts General Hospital. Her research interests focus on early detection of dementia via subjective concerns of cognitive decline (working with Dr. Rebecca Amariglio), and understanding how resting-state functional connectivity is related to AD biomarkers in predicting pathological cognitive decline (with Drs. Aaron Schultz and Jasmeer Chhatwal). She is also affiliated with The Florey Institute of Neuroscience and Mental Health and the University of Melbourne in Australia, and is a lead investigator of the Australian Healthy Brain Project, an online study of genes and longitudinal cognitive change in middle aged Australians ( Her work is supported by the NHMRC National Institute for Dementia Research, Australian Research Council, Alzheimer's Association and the Brain Foundation.

Jenny S. Rabin PhD

Jenny S. Rabin, PhD is completing a joint clinical and research postdoctoral fellowship at Massachusetts General Hospital/Harvard Medical School. Her research is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). She completed her PhD in clinical psychology (neuropsychology stream) at York University in Toronto and her predoctoral internship (neuropsychology tract) at Massachusetts General Hospital/Harvard Medical School. Her research in the lab currently focuses on assessing: 1) the relationship between diffusion white matter characteristics and cognitive decline in healthy older adults; 2) the relationship between cardiovascular disease, brain markers, and cognitive decline in healthy older adults; and 3) the relationship between Connectome-derived diffusion characteristics of the fornix and memory performance across the Alzheimer’s disease spectrum.

Julie Price PhD

Julie Price is Professor of Radiology at the Harvard Medical School and Investigator at the MGH Department of Radiology. She is Director of PET Pharmacokinetic Modeling at the MGH/HST Martinos Center for Biomedical Imaging.  Her expertise is in quantitative PET methods for translational imaging of protein targets, blood flow and glucose metabolism including studies of aging, neurodegeneration, and neuropsychiatric disorders.  Her main research involves PET imaging of amyloid-beta and (more recently) tau protein deposits in the validation and application of biomarkers of Alzheimer’s disease.  Previously at the University of Pittsburgh (1994-2016), she worked with colleagues (Mathis, Klunk, et al) to help establish Pittsburgh Compound-B (or PiB) as an amyloid imaging agent for human use and was Head of PET Methodology there from 2002-2016. She completed physics and medical physics degrees at the University of Wisconsin (Madison), doctoral training (specializing in radiation health sciences) at Johns Hopkins University, and post-doctoral training at the NIH PET/Nuclear Medicine Department.  She was Chair of the NIH Clinical Neuroscience and Neurodegeneration study section (2013-15).

Heidi Jacobs PhD

Heidi Jacobs has master degrees in neuropsychology, psychopathology and developmental psychology and is a certified behavioral psychotherapist and clinical neuropsychologist in both Belgium and the Netherlands. After several years of clinical work, she received her PhD in the Netherlands (within 2nd percentile) in cognitive neuropsychiatry and clinical neurosciences at Maastricht University in 2011. After her PhD, she became a postdoctoral fellow at the Research Center Juelich (Germany), continuing her work on structural and functional MRI in early Alzheimer’s disease. After her postdoc, she received a VENI award and returned to the Netherlands as a tenured assistant professor. Currently, she is an instructor at Harvard Medical School and at the Department of Radiology of Massachusetts General Hospital. Her main interests are focused on understanding the disease mechanisms of Alzheimer’s disease by investigating the interaction of biomarkers and other brain changes, such as structural and functional connectivity, and how these mechanisms relate to cognitive changes. She also has a strong interest in understanding the modulatory effect of brainstem nuclei, in particular the locus coeruleus, on cognition and brain integrity within the context of aging and dementia.

Jonathan Jackson PhD

Jonathan Jackson, PhD is a cognitive neuroscientist on faculty at Massachusetts General Hospital via Harvard Medical School, investigating the early detection of Alzheimer’s disease (AD), particularly in the absence of overt memory problems. He has particular interest in topics such as attentional control, episodic memory, the brain’s connectivity, subjective concerns, and health disparities. Jonathan also serves on Massachusetts General Hospital’s Alzheimer’s Disease Research Center (ADRC) and MGH’s Cancer Center Equity Program, specializing in identifying and overcoming barriers to clinical research for people and communities of color. His research focuses on midlife and late-life health disparities in clinical settings that affect Black populations, relevant to both dementia and oncology research. He has become a well-known MGH representative to communities of color and dozens of affiliated organizations, particularly regarding clinical research. Dr. Jackson serves on the leadership team of several organizations focused on community health, as well as local, statewide, and national advisory groups for AD.

Rodrigo Dennis Perea PhD

Rodrigo Perea, PhD was born and raised in Arequipa, Peru. He obtained his BS in computer engineering and MS/PhD in bioengineering in Lawrence, Kansas. His research interests focus on developing diffusion imaging pipelines and optimizing methods for understanding the effects of cognition, aging and Alzheimer’s disease in structural white matter connectivity. Currently, he is trying to understand whether distinctive diffusion and volumetric features exist in the fornix bundle in a sample of age- and gender- matched healthy older adults vs. early Alzheimer participants using enhanced high-gradient multi-shell diffusion weighted images as part of the MGH-Harvard-USC Adult Human Connectome Project. His future research interests include characterizing the structural connectivity integration or lack of it in other in-vivo imaging techniques using molecular (PET amyloid/tau) and functional (fMRI) imaging. If he is not doing research, he is most likely playing soccer, mountain biking, dancing, playing guitar, video-games or reading about astronomy or psychology.

Hyun-Sik Yang MD

Hyun-Sik Yang, MD is a behavioral neurology fellow at Brigham and Women’s Hospital and a clinical Alzheimer disease research fellow at Center for Alzheimer Research and Treatment. Dr. Yang’s clinical interest is on neurodegenerative dementias, and his research focuses on disease modifiers of Alzheimer’s disease such as genetic/epigenetic variations, coexisting neuropathologies, and medical comorbidities. Dr. Yang is a sub-investigator and a study physician (neurologist) in HABS.

Bernard Hanseeuw MD, PhD

Bernard is a behavioral neurologist coming from Belgium. He aims to better understand the biological mechanisms leading to Alzheimer's pathology (amyloid plaques, tau tangles) to guide preventive clinical trials and give better care to patients and families. He heard about the Harvard Aging Brain Study at the Alzheimer's Association International Conference (AAIC) in Boston, 2013 and joined the team a year later. His current research focuses on longitudinal amyloid and tau PET imaging in clinically normal and mildly impaired older adults. The goal of this research is to evaluate how amyloid and tau accumulate with age, to determine which factors influence this accumulation, and what could be done to prevent it. Besides his research activities, Bernard conducts neurological examinations for the Harvard Aging Brain study and he is a member of the Speaker bureau of the Massachusetts Alzheimer's Disease Research Center.

Edmarie Guzmán-Vélez PhD

Dr. Guzmán-Vélez is a postdoctoral fellow in the Familial Dementia Neuroimaging Lab. She completed her doctoral training in clinical psychology at the University of Iowa in Dr. Daniel Tranel’s laboratory, and her internship in neuropsychology at the Boston VA. Her research has focused on examining the dissociation between declarative memory and emotions in patients with Alzheimer’s disease. Her current interests in the lab include studying how functional connections in the brain change years before individuals develop symptoms associated with Alzheimer’s disease (preclinical stage) and how these relate to cognition and genetic factors. She also conducts neuropsychological evaluations in the Mass General Multicultural Neuropsychology Program (MUNDOS). She enjoys cooking, spending time with friends and family, traveling, dancing, and exercising.


Coordinators, Research Assistants and Study Staff


Paige Sparks

Paige Sparks is a Senior Clinical Research Coordinator with the Harvard Aging Brain Study. Before joining the HABS team in 2015, she graduated from Boston University with a BA in Political Science. She is interested in early detection in Alzheimer’s Disease, as well as racial differences in cognition and pathology related to the disease.

Emily Kilpatrick

Emily is a Senior Clinical Research Coordinator. She received her Bachelor of Science in Physiology and Neurobiology from the University of Connecticut in 2010.  She worked as a pharmacy technician for several years before joining the Harvard Aging Brain Study in 2015.  She is interested in better understanding the pathology of Alzheimer’s Disease and other causes of dementia to improve methods of early detection.

Irina Orlovsky

Irina is involved in coordination of various components of the Harvard Aging Brain Study including neuropsychological testing, scheduling study visits, substudy participation, and phlebotomy. She also serves as a psychometrician at the Center for Alzheimer Research and Treatment for symptomatic and asymptomatic clinical trials. After graduating from the University of Massachusetts, Amherst with a degree in Neuroscience and Psychology, Irina pursued a Masters in Psychology at Brandeis University with a research concentration in cognitive aging. More recently, Irina has expanded on her research in aging and associative memory to investigate the utility of semantic memory in early detection of AD due to dementia, at the preclinical stage.

Martha Muñiz

Martha C. Muñiz is a Clinical Research Coordinator for the Harvard Aging Brain Study, assisting in data collection and neuropsychological testing. She graduated from San Diego State University with a Bachelor’s degree in psychology. Martha furthered her education at Boston University, attaining a Master of Arts degree in psychology. Her interest in working with the aging population was sparked by her close relationship with her grandparents.

Lyssa Manning

Lyssa received her Bachelor of Arts in Psychology ('14) and Master of Science in Neuroscience ('17) degrees from McGill University in Montreal, Canada. She has worked in aging and neuroimaging for three years prior to joining the Harvard Aging Brain study and is excited to continue learning about early detection of cognitive decline in pathological aging with the excellent team here at HABS.

Aubryn Samaroo

Aubryn graduated from Brown University in 2017 with a double major in Cognitive Neuroscience and Education Studies. Aubryn was on the track and field team at Brown as a high jumper. She is from Michigan. She is interested in investigating the underlying causes of memory loss and its impacts on mental health to create better and earlier treatments.

Taylor Neal

Taylor Neal is a Clinical Research Coordinator in Dr. Trey Hedden’s lab within the Harvard Aging Brain Study. She graduated from Boston University in May of 2016 with Bachelor’s degrees in neuroscience and psychology. Since starting at MGH a year ago, she has been grateful for the opportunity to learn first-hand about neuroimaging and neuropsychology tools, as well as to work with all of the amazing participants in HABS. Taylor hopes to continue studying aging and memory through a graduate program in the future.

Nora Downey

Nora Downey is a Clinical Research Coordinator in Dr. Trey Hedden’s lab.  As a prospective medical student and aspiring geriatrician, she is enthusiastic about all aspects of working with the Harvard Aging Brain Study.  She is incredibly grateful for all the experiences this position provides, from interacting with patients and administering neuropsychological testing, to learning about neuroimaging through data acquisition and exposure to data analysis.  Before coming to MGH, Nora worked for two years in a microbial genetics laboratory at the Marine Biological Laboratory in Woods Hole.  Previously, she studied the neurological processes that take place during meditation while studying at Hanseo University in Seosan, South Korea.  Nora graduated from the University of Massachusetts Amherst in 2012 with a BA in Anthropology.  She is broadly interested in the biopsychosocial approach to medical care.

Federico d’Oleire Uquillas

Federico d’Oleire Uquillas attended UC Berkeley for his undergraduate studies. There, he received training in psychophysiological recording, transcranial magnetic stimulation (TMS), and magnetic resonance imaging (MRI) at 3-Tesla. As part of the HABS team, Federico helps collect, process, and analyze neuroimaging data. His recent research interests have focused on how functional and structural neural correlates of impaired insight of memory deficits are influenced by Beta-amyloid deposition and other biomarkers of aging and Alzheimer’s disease dementia. He is also interested in functional dynamic connectivity of resting-state networks in cognitive aging, and in the monitoring of learning in higher cognitive processes.

Olivia Hampton

Olivia graduated from Boston College in 2017 with a Bachelor of Science in Psychology. During her undergrad, her research used neuroimaging, polysymnography, and neurophysiology techniques to observe the relationship between sleep and stress on emotional memory. Olivia is looking forward to the opportunity to expand her research and better understand the pathology of Alzheimer’s Disease.

David Jin

David graduated from MIT in 2016 with a B.S. in Brain and Cognitive Sciences and a minor in Economics. His undergraduate experiences involved research into visual cognition and autism, as well as work with Project Prakash, a non-profit organization dedicated to treatment of blindness in India while simultaneously learning about the onset of sight. He is interested in understanding their application to studying the aspect of neurodegeneration in neurological disorders.

Sam Katz

Sam recently graduated from Washington University in St. Louis with a B.A. in Psychology-Neuroscience-Philosophy (PNP) and Biology. In college, she researched pediatric orthopedic injuries. She is excited to shift her focus to learn more about the imaging and pathology of Alzheimer’s Disease.

Evelyn Luner

Evelyn graduated from the College of William & Mary in 2016 with a BS in Neuroscience and a minor in Public Health. As an undergraduate she studied the effects of nicotine on fear and context-dependent memory retrieval. Now she is excited to explore a different area of the neuroscience field and gain experience in clinical research.

Kirsten Moody

Kirsten graduated from Northeastern University in 2017 with a B.S. in Mathematics and minors in Psychology and Biology. She was a research assistant in Pediatric Neurology at MGH who aided in administering clinical trials of cannabidiol to children affected with epilepsy, specifically Tuberous Sclerosis Complex. She also became very interested in the psychological comorbidities, subependymal giant cell tumors, and other related symptoms of patients with TSC. Although she enjoyed working with children, she is eager to shift to the other end of the age spectrum and investigate the aging brain.

Justin Sanchez

Justin graduated from Harvard College in May with an B.A. in Neurobiology and a minor in Government. His undergraduate thesis investigated everyday structural changes in the brains of young, healthy people, and he is excited to continue studying the processes of normal and abnormal aging.



Administrative Staff


Dylan Kirn MPH

Dylan is the clinical research project manager. He is responsible for the operational requirements for observational research trials, including the Harvard Aging Brain Study.  His research interests include how physical activity may influence the risk of developing Alzheimer’s disease, and the relationship between physical functioning and brain health in older adults.  He received his undergraduate degree from Springfield College in Applied Exercise Science, and his Master of Public Health degree from Tufts University School of Medicine.  

Michael Properzi

Ashley Deskins


Interns and Volunteers 



 Julia Sherman

 Courtney Martin

 Michaela Mentzer

Vaishnivi Rao



Harvard Aging Brain Alumni


Sarah Wigman

Jon Bruno

Margaret Chute

Alex Dagley

Alayna Younger

Lesley Pepin

Jackie Maye

Chris Gidiscin

Lauren Wadsworth

Natacha Lorius

Caroline Sullivan

Marlie Philiossaint

Nayiri Arzoumanian

Elie Kercine

Jonathan Alverio

Samantha Mauro

Andrew Ward

Sehily Jaimes

Sarah Aghjayan

Tamy-Fee Meneide

Katie Munro

Victoria Jonas